Cansino Biologics (China) Probability of Future Stock Price Finishing Under 62.59

688185 Stock   62.11  5.49  8.12%   
Cansino Biologics' future price is the expected price of Cansino Biologics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Cansino Biologics performance during a given time horizon utilizing its historical volatility. Check out Cansino Biologics Backtesting, Cansino Biologics Valuation, Cansino Biologics Correlation, Cansino Biologics Hype Analysis, Cansino Biologics Volatility, Cansino Biologics History as well as Cansino Biologics Performance.
  
Please specify Cansino Biologics' target price for which you would like Cansino Biologics odds to be computed.

Cansino Biologics Target Price Odds to finish below 62.59

The tendency of Cansino Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under  62.59  after 90 days
 62.11 90 days 62.59 
about 87.68
Based on a normal probability distribution, the odds of Cansino Biologics to stay under  62.59  after 90 days from now is about 87.68 (This Cansino Biologics probability density function shows the probability of Cansino Stock to fall within a particular range of prices over 90 days) . Probability of Cansino Biologics price to stay between its current price of  62.11  and  62.59  at the end of the 90-day period is near 1 .
Assuming the 90 days trading horizon Cansino Biologics has a beta of -0.14. This suggests as returns on the benchmark increase, returns on holding Cansino Biologics are expected to decrease at a much lower rate. During a bear market, however, Cansino Biologics is likely to outperform the market. Additionally Cansino Biologics has an alpha of 0.8108, implying that it can generate a 0.81 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Cansino Biologics Price Density   
       Price  

Predictive Modules for Cansino Biologics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cansino Biologics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
56.6662.1167.56
Details
Intrinsic
Valuation
LowRealHigh
43.9649.4168.32
Details
Naive
Forecast
LowNextHigh
57.7363.1768.62
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cansino Biologics. Your research has to be compared to or analyzed against Cansino Biologics' peers to derive any actionable benefits. When done correctly, Cansino Biologics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cansino Biologics.

Cansino Biologics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cansino Biologics is not an exception. The market had few large corrections towards the Cansino Biologics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cansino Biologics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cansino Biologics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.81
β
Beta against Dow Jones-0.14
σ
Overall volatility
10.59
Ir
Information ratio 0.13

Cansino Biologics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cansino Biologics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cansino Biologics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cansino Biologics is way too risky over 90 days horizon
Cansino Biologics appears to be risky and price may revert if volatility continues
The company reported the revenue of 345.18 M. Net Loss for the year was (1.45 B) with loss before overhead, payroll, taxes, and interest of (183.71 M).
Cansino Biologics generates negative cash flow from operations
About 63.0% of the company shares are owned by insiders or employees

Cansino Biologics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cansino Stock often depends not only on the future outlook of the current and potential Cansino Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cansino Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding247.4 M

Cansino Biologics Technical Analysis

Cansino Biologics' future price can be derived by breaking down and analyzing its technical indicators over time. Cansino Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cansino Biologics. In general, you should focus on analyzing Cansino Stock price patterns and their correlations with different microeconomic environments and drivers.

Cansino Biologics Predictive Forecast Models

Cansino Biologics' time-series forecasting models is one of many Cansino Biologics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cansino Biologics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Cansino Biologics

Checking the ongoing alerts about Cansino Biologics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cansino Biologics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cansino Biologics is way too risky over 90 days horizon
Cansino Biologics appears to be risky and price may revert if volatility continues
The company reported the revenue of 345.18 M. Net Loss for the year was (1.45 B) with loss before overhead, payroll, taxes, and interest of (183.71 M).
Cansino Biologics generates negative cash flow from operations
About 63.0% of the company shares are owned by insiders or employees

Other Information on Investing in Cansino Stock

Cansino Biologics financial ratios help investors to determine whether Cansino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansino with respect to the benefits of owning Cansino Biologics security.